Peijia Medical Limited (HKG:9996)
Hong Kong · Delayed Price · Currency is HKD
5.70
+0.05 (0.88%)
At close: Mar 4, 2026
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
|---|
Neurointerventional Business | 355.55M | 255.56M | 143.52M | 94.59M | 38.66M | | |
Neurointerventional Business Growth | 39.13% | 78.06% | 51.73% | 144.71% | 106.72% | | |
Transcatheter Valve Therapeutic Business | 259.94M | 185.57M | 107.31M | 41.94M | - | | |
Transcatheter Valve Therapeutic Business Growth | 40.07% | 72.93% | 155.86% | - | - | | |
| 615.48M | 441.13M | 250.83M | 136.53M | 38.66M | | |
| 39.53% | 75.86% | 83.71% | 253.21% | 106.72% | | |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
|---|
| 615.48M | 441.13M | 250.83M | 136.53M | 38.66M | | |
| 39.53% | 75.86% | 83.71% | 253.21% | 106.72% | | |
| 615.48M | 441.13M | 250.83M | 136.53M | 38.66M | | |
| 39.53% | 75.86% | 83.71% | 253.21% | 106.72% | | |
Source: S&P Global Market Intelligence.
